prevalence of 1-2% in Canada. Our hypothesis is PAE overwhelms the aldehyde metabolic enzymes that would normally convert retinol (Vitamin A) to retinoic acid (RA) and reduced RA levels during critical developmental times in early gastrulation underlie the later malformations associated with FAS.
Methods: To biochemically mimic the alcohol-induced RA deficiency in vivo, we genetically engineered a mouse expressing Cyp26A1-eGFP from the endogenous Gsc promoter. The Gsc promoter dictates spatial-temporal expression to the Spemann Mangold Organizer at the start of gastrulation. Cyp26A1 degrades endogenous RA in these cells, mimicking the reduced RA levels induced by acute alcohol exposure and dysregulating the induction of neural crest cells.
Results: Gsc:Cyp26A1 mice were derived by germline transmission; F1 mice are born with a Mendelian ratio of 0.75:1 (het:wt, n= 208). This loss of mutant embryo viability may reflect the prevalent miscarriages observed in human pregnancies with PAE. Gsc: Cyp26A1xRARE-LacZ E8.5 embryos show reduction in RA activity in the frontonasal prominence region (LacZ expression in early face and forebrain). Mutant embryos also demonstrate body-axis developmental variation, indicating early developmental perturbation of RA pathways in FASD relevant tissues (n =48). E18.5 embryos were next examined using scanning EM to demonstrate mutant embryos have sentinel FASD craniofacial malformations: larger philtrum-tophiltrum-lip length ratio, smaller bigonial line width, and smaller whisker pad area (n =66). Gsc:Cyp26A1 mice also develop craniofacial malocclusions at significantly higher rates than WT littermates (12.5% vs 0.04%; n= 208 and 3711, respectively).
Conclusion: Our data provide in vivo evidence that strongly supports RA-deficiency as a major molecular etiology of craniofacial malformations associated with FASD. The finding suggests Vitamin A supplementation may significantly reduce or prevent FASD outcomes in children with PAE. Embryogenesis is a precisely regulated process that requires tight coordination of events in space and, as importantly, in time, yet currently it is unknown how embryos ensure temporally robust development. Embryos are exposed to both endogenous and exogenous cues; yet they reliably develop to their final shape within a predictable timeframe. The process of embryogenesis is therefore able to account and to correct for environmental and intra-embryo noise. Here, we develop procedures to analyze temporal robustness at the whole organism level. Using Drosophila embryos maintained at precise temperatures, we simultaneously image up to 60 embryos from early embryogenesis until larvae hatching. We time the stage of embryogenesis by identifying developmental landmarks. We found that there exists an optimal developmental temperature (21°C) at which the temporal variation between embryos is minimal.
In accordance with previous studies, embryos develop faster at higher temperatures. Whilst this observation can be partially explained by the faster kinetics of various processes at increasing temperature, we next investigated whether active temporal regulators are present, which may, for example, coordinate tissue growth with developmental time. Coupling our setup with microarray analysis and qPCR, we have identified 22 miRNAs that are differentially regulated at varying temperature during embryogenesis. These miRNAs have a broad spectrum of action but, despite being expressed during embryogenesis, their absence does not prevent hatching. Hence, they may have a subtler role, possibly ensuring coordination between developmental processes. We are currently using miRNA knockout and miRNA overexpression to further understand their role in controlling developmental time. Our work represents the first quantitative analysis of temporal variation in embryogenesis and the setup we have developed enables us to explore how time is effectively regulated during embryogenesis. The Ferritin heavy polypeptide-like 17 (Fthl17) gene is a member of the cancer/testis antigen (CTA) genes, which are expressed only in cancer cells and in germ cells. Although previous studies suggested correlation between DNA methylation and the expression of CTA genes including human FTHL17 gene expression, detailed epigenetic regulation of its expression both in cancer cells and in germ cells has not been investigated. To find out regulatory mechanism of Fthl17 gene expression, we assessed the epigenetic regulation of murine Fthl17 gene expression in lung cancer cells and in germline stem cells (GSCs). Fthl17 was more highly expressed in testis, a murine lung cancer cell line, KLN205, and in GSCs than in normal lung tissues. Furthermore, the Fthl17 expression level in GSCs was significantly higher than in KLN205 cells. By bisulfite-sequencing and luciferase reporter assay, we indicated that the 5'-upstream region of Fthl17 was hypo-methylated in KLN205 cells and in GSCs, and hypo-methylation of the -0.6 kb to 0 kb region upstream from the transcription start site (TSS) was involved in its up-regulation in those cells. Because the -0.6 kb to -0.3 kb and the -0.3 kb to 0 kb region were relatively more hypo-methylated in KLN205 cells and in GSCs, respectively, it was suspected that hypo-methylation of the -0.3 kb to 0 kb region caused remarkable increase of Fthl17 expression. Consisting with this idea, treatment with 5-Azacytidine induced hypo-methylation of the -0.3 kb to 0 kb region and upregulation of its expression in KLN205 cells to a level comparable to that in GSCs. Together, our results suggest that hypo-methylation of different but adjacent regions immediately upstream of the Fthl17 gene contribute to differential expression levels in lung cancer cells and in GSCs, and hypo-methylation of the TSS-proximal region is critical for its high-level expression. Nitric oxide plays an important role in stem cell differentiation and in endothelial cells it is expressed by endothelial nitric oxide synthase (eNOS) which is located within membrane caveolae through scaffolding with caveolin-1 (CAV-1WT) which inhibits NO production. In this study, we modified rat bone marrow mesenchymal stem cells (rBMSCs) with lentiviral vectors to co-express eNOS and mutant caveolin-1 (CAV-1F92A) to enhance NO generation and investigated endothelial reprogramming. A lenti-eNOS-GFP fusion vector which allowed FACS selection of eNOS positive cells increased NO production (6.9 ± 0.8 μM) compared to GFP alone (1.04 ± 0.22 μM) and un-transduced cells (0.91± 0.35 μM) (pb0.05). eNOS-GFP and GFP cells were further re-transduced with CAV-1F92A or CAV-1WT. rBMSCeNOS+ CAV-1F92A showed enhanced in vitro capillary tubule formation, upregulation of endothelial specific CD31, V-cadherin gene expression which was reversed by treatment with the eNOS inhibitor L-NAME. Activity of an endothelial specific FLT1-eGFP lentiviral-reporter was also increased compared to controls. Furthermore, arterial specific Notch1, Hey 1 and DII4 gene expression was increased in rBMSCeNOS+ CAV-1F92A whereas venous specific COUP-TFII and lymphatic specific Prox1 expression was significantly reduced. Canonical Wnt3A gene expression was increased in rBMSCeNOS +CAV-1F92A and treatment with L-NAME, resulted in reduced CD31 and Wnt3A expression, and the Wnt inhibitor Dkk-1 also decreased CD31 expression. Western blot analysis showed increased β-catenin expression in rBMSCeNOS +CAV-1F92A confirming the relationship between NO and Wnt/β-catenin signaling. Furthermore rBMSCeNOS+CAV-1F92A cells showed decreased histone deacytaylase SIRT6 and DNA methyltransferase DNMT1 expression which was reversed with L-NAME treatment highlighting that NO may drive epigenetic modification during reprogramming. Finally, subcutaneous implantation of the rBMSCeNOS +CAV-1F92A cells seeded in polyurethane scaffolds in rats, resulted in formation of blood vessels. In summary, our data suggest that nitric oxide activates Wnt/-β-catenin signaling to promote endothelial reprogramming of BMSCs and may provide a novel platform for vascular repair. Transcription factor (TF) binding to DNA is fundamental for gene regulation. However, it remains unknown how the dynamics of TF-DNA interactions change during cell fate determination in vivo. Here, we use photo-activatable fluorescence correlation spectroscopy (paFCS) to quantify TF-DNA binding in single cells of developing mouse embryos, and reveal the dynamic repartitioning of TFs between distinct DNA sites driven by epigenetic changes. In blastocysts, the TFs Oct4 and Sox2, which control pluripotency, bind DNA more stably in pluripotent than extraembryonic cells. By contrast, in 4-cell embryos, Sox2 engages in more long-lived interactions than Oct4. The homeodomain transcription factor NKX2-5 is essential for the development and normal physiology of the vertebrate heart. However, despite extensive analyses, the direct downstream effectors of NKX2.5 function during the differentiation of cardiac progenitor cells (CPCs) are largely unknown. We have identified Furin, which is coding for a proprotein convertase, as a direct transcriptional target of NKX2-5 and studied its role during cardiac development.
Using a genome wide distribution approach we found a region close to the Furin gene enriched for NKX2-5 binding. That region is able to drive LacZ expression in a transgenic mouse assay in a pattern comparable to that of the endogenous Furin. On a Nkx2-5 null mutant background, the expression of the Furin-enhancer-LacZ transgene is upregulated in the heart in a similar way as the endogenous Furin mRNA is in the same mutant embryos. Moreover, heart expression of endogenous Furin is downregulated when that enhancer is deleted in a mutant mouse model. Taken together those results show that we have identified a cardiac enhancer of Furin, directly repressed by NKX2-5.
To assess the function of Furin we specifically deleted its expression in CPCs using a conditional mouse knockout. Cardiomyocyte specific mutant embryos for Furin show a whole series of cardiac abnormalities including ventricular septal defect and a range of defects in the outflow tract formation. Moreover, premature expression of cardiac differentiation markers in the CPCs of the anterior heart field of the mutant embryos suggests a role for Furin in the differentiation of those cells. Twist1 encodes a basic helix-loop-helix domain (bHLH) transcription factor that regulates the differentiation of cranial neural crest and head mesoderm during craniofacial development. To gain insight into the transcriptional network in which TWIST1 operates, we identified TWIST1 interacting proteins in mouse neural crest stem cells and fibroblasts. Using the BioID proteomic approach, we were
